Motilal Oswal initiates Aster DM at Buy, target Rs 910
In short
Motilal Oswal started coverage on Aster DM Quality Care with a Buy rating and a Rs 910 target price. It expects revenue to grow 19.5% a year, EBITDA 25% a year, and PAT 33% a year through FY28.
The brokerage says merger synergies and expansion should help the company. The report does not say if the stock already reacted or when the target might be hit.
What the reporting says
Motilal Oswal initiated coverage on Aster DM Quality Care with a Buy rating and a Rs 910 target, citing merger synergies, capacity expansion and improving operating metrics. The brokerage expects revenue, EBITDA and PAT to grow at CAGRs of 19.5%, 25% and 33% through FY28. The reporting does not say whether the stock has already moved or when the target may be reached.
Why it matters
The brokerage note is positive for Aster DM Quality Care because it lifts the stock with a Buy rating and a specific target of Rs 910. The forecast suggests faster earnings growth than revenue growth, implying margin improvement from synergies and scale. But the report is only an analyst view, so execution risk and actual financial performance remain uncertain.